Gene therapy for treating Mucopolysaccharidosis type II Grant US-11819539-B2 United States of America 21 Nov 2023
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS… Grant US-11613739-B2 United States of America 28 Mar 2023
Gene therapy for treating mucopolysaccharidosis type II Grant US-11253612-B2 United States of America 22 Feb 2022
ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM Application US-20210369871-A1 United States of America 02 Dec 2021
Delivery of therapeutic compounds to the brain and other tissues Grant US-11040088-B2 United States of America 22 Jun 2021
Glucocerebrosidase gene therapy for Parkinson's disease Grant US-10967073-B2 United States of America 06 Apr 2021
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS… Application US-20200149019-A1 United States of America 14 May 2020
TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2… Application EP-2793933-A4 European Patent Office 08 Jun 2016